文献速递乳房整形与再造

延迟直接置入假体乳房再造:一种替代组织扩张的方案

From 0 to 100: Delayed Direct to Implant Breast Reconstruction, an Alternative to Tissue Expansion.
PubMed 文献 · Ann Plast Surg · 2025-01-01

本研究评估乳房切除术后先「平胸」患者 later 行延迟直接置入假体(dDTI)再造的可行性,并与延迟组织扩张器(TE)后置入假体再造比较。2022–2024年纳入36例患者(64侧乳房,TE 31侧、dDTI 33侧),dDTI并发症少于TE(3.0% vs 35.5%,P<0.01)。结论认为dDTI是TE的安全替代,至少可少一次手术和多次门诊。

要点

  • dDTI并发症3.0%,低于TE的35.5%(P<0.01)。
  • dDTI可作为TE的安全替代,尤其假体再造不可行时。
  • dDTI至少节省一次额外手术和多次门诊。

核心结论

  • dDTI似乎是TE的安全替代方案,尤其当基于假体的再造不可行时。
  • 该技术至少为患者节省一次额外手术和多次门诊就诊。

研究设计与样本

  • 纳入2022–2024年乳房切除时无法再造、 later 未用组织扩张器直接置入假体的患者,并与延迟组织扩张器后置入假体再造的患者比较。
  • 共36例患者(64侧乳房),其中TE 31侧、dDTI 33侧;平均年龄52±13岁,平均BMI 26.3±4.8 kg/m2。

主要发现

  • dDTI并发症少于TE(3.0% vs 35.5%,P<0.01)。
  • 单因素logistic回归显示dDTI患者发生并发症的比值显著低于TE(OR 0.06 [0.01-1.22];P<0.01)。
  • 乳房切除至dDTI的平均时间为278.9±180.2天。

临床怎么用

  • 对于乳房切除术后先「平胸」且假体再造不可行的患者,可考虑延迟直接置入假体(dDTI)而非组织扩张。
  • dDTI可减少并发症,并至少避免一次额外手术和多次门诊就诊。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Implant-based reconstruction is not always feasible when mastectomy flap viability is poor. Rather than returning to the operating room for staged breast reconstruction with tissue expansion (TE), patients may instead opt for delayed direct to implant (dDTI) reconstruction. This study aimed to assess the feasibility of dDTI after patients "go flat" after their mastectomy. METHODS: Patients unable to undergo breast reconstruction at the time of their mastectomy and who later underwent implant placement without tissue expanders between 2022 and 2024 were included in this study. These patients were compared with patients who underwent delayed tissue expander to implant-based reconstruction. RESULTS: A total of 36 patients (64 breasts) were included in the study (31 TE and 33 dDTI breasts). The average age was 52 ± 13 years, and average body mass index was 26.3 ± 4.8 kg/m2. The mean time between mastectomy and dDTI was 278.9 ± 180.2 days. dDTI had fewer complications than TE (3.0% vs 35.5%, P < 0.01). Univariate logistic regression showed that patients with dDTI had significantly lower odds of having complications compared with TE (odds ratio, 0.06 [0.01-1.22]; P < 0.01). CONCLUSIONS: dDTIs appear to be a safe alternative to TE, especially when implant-based reconstruction is not feasible. This technique saves the patient, at minimum, an additional surgery and multiple clinic visits that would have been required if tissue expanders were used.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Le NK, Whalen K, Olafson A, et al. From 0 to 100: Delayed Direct to Implant Breast Reconstruction, an Alternative to Tissue Expansion. Ann Plast Surg. 2025. PMID: 40459452. doi:10.1097/SAP.0000000000004384

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。